argenx to Present at BofA Securities 2022 Healthcare Conference
May 04 2022 - 1:00AM
May 4,
2022Breda, the Netherlands – argenx
(Euronext & Nasdaq: ARGX), a global immunology company
committed to improving the lives of people suffering from severe
autoimmune diseases, today announced that members of management
will participate in a fireside chat at the BofA Securities 2022
Healthcare Conference on Wednesday, May 11, 2022 at 10:40 a.m. P.T.
in Las Vegas, NV.
A live webcast of the presentation may be
accessed on the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately 90 days following the
presentation.
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases.
Partnering with leading academic researchers through its Immunology
Innovation Program (IIP), argenx aims to translate immunology
breakthroughs into a world-class portfolio of novel antibody-based
medicines. argenx developed and is commercializing the
first-and-only approved neonatal Fc receptor (FcRn) blocker in the
U.S. and Japan. The Company is evaluating efgartigimod in multiple
serious autoimmune diseases and advancing several earlier stage
experimental medicines within its therapeutic franchises. For more
information, visit www.argenx.com and follow us on LinkedIn,
Twitter, and Instagram.
For further information, please contact:
Media:
Kelsey Kirkkkirk@argenx.com
Investors:
Beth DelGiaccobdelgiacco@argenx.com
Michelle Greenblattmgreenblatt@argenx.com
Argen X (EU:ARGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Argen X (EU:ARGX)
Historical Stock Chart
From Apr 2023 to Apr 2024